A Case of Biopharmaceutical-Induced Catatonia and the Implication of a Novel Mechanism.
Journal
The journal of ECT
ISSN: 1533-4112
Titre abrégé: J ECT
Pays: United States
ID NLM: 9808943
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
pubmed:
3
3
2020
medline:
17
7
2021
entrez:
3
3
2020
Statut:
ppublish
Résumé
Catatonia can be described structurally as a motor dysregulation syndrome with a concomitant behavioral component. However, despite its initial recognition nearly 150 years ago, the exact pathophysiological causes underlying this syndrome are still somewhat unknown and are potentially variable. This report reviews a case of a patient with multiple catatonic episodes precipitated by the use of an immunomodulator medication, and in doing so suggests a possible mechanism speaking to the immune system's role in the etiology of some cases of catatonia.
Identifiants
pubmed: 32118686
doi: 10.1097/YCT.0000000000000650
pii: 00124509-202009000-00020
doi:
Substances chimiques
Biological Products
0
Etanercept
OP401G7OJC
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e29-e30Références
Tanguturi YC, Cundiff AW, Fuchs C. Anti-N-methyl-d-aspartate receptor encephalitis and electroconvulsive therapy. Child Adolesc Psychiatr Clin N Am. 2019;28:79–89.
Rogers JP, Pollak TA, Blackman G, et al. Catatonia and the immune system: a review. Lancet Psychiatry. 2019;6:620–630.
Guloksuz S, Rutten BP, Arts B, et al. The immune system and electroconvulsive therapy for depression. J ECT. 2014;30:132–137.
Ellul P, Choucha W. Neurobiological approach of catatonia and treatment perspectives. Front Psych. 2015;6:182.
Yrondi A, Sporer M, Peran P, et al. Electroconvulsive therapy, depression, the immune system and inflammation: a systematic review. Brain Stimul. 2018;11:29–51.